Shares outstanding increased 65.1%
Shares outstanding changed +65.1% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +65.1% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Cash & equivalents changed +46.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash flow changed +388.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current liabilities changed +136.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory changed +154.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Total assets changed +424.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross debt changed +249.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net debt changed +317.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Reported total debt changed +249.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Revenue changed +113.3% from the comparable as-filed period.
Operating margin changed -2963 basis points from the comparable as-filed period.
Working capital / assets changed -789 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +151.3% from the comparable as-filed period.
Selling, general & administrative changed +101.2% from the comparable as-filed period.
Inventory / revenue changed +1360 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.